Literature DB >> 19675999

New animal models for autoimmune hepatitis.

Urs Christen1, Edith Hintermann, Elmar Jaeckel.   

Abstract

Autoimmune hepatitis (AIH) is often diagnosed late in the disease course and usually requires lifelong immunosuppressive therapy. Unfortunately, the etiology of the disease and the mechanisms leading to the autoimmune destruction of the liver parenchyma are only poorly understood. For a long time, one reason for this lack of apprehension was the absence of reliable animal models with a chronic immune response against liver tissues. Initial attempts to break tolerance against hepatocytes usually just resulted in mild, transient hepatitis flares. Recently, however, some approaches have been made to establish models of chronic AIH that reflect the immunopathogenic mechanisms seen in humans. In this article, we reflect on recent models, focusing on their feasibility and chances for success in providing a platform for studying the mechanisms of autoimmune liver destruction and the development of possible therapeutic interventions. Copyright Thieme Medical Publishers.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19675999     DOI: 10.1055/s-0029-1233536

Source DB:  PubMed          Journal:  Semin Liver Dis        ISSN: 0272-8087            Impact factor:   6.115


  10 in total

1.  Cytochrome P450 2D6 as a model antigen.

Authors:  Urs Christen; Martin Holdener; Edith Hintermann
Journal:  Dig Dis       Date:  2010-05-07       Impact factor: 2.404

Review 2.  Tolerogenic dendritic cells and myeloid-derived suppressor cells: potential for regulation and therapy of liver auto- and alloimmunity.

Authors:  Sudha Natarajan; Angus W Thomson
Journal:  Immunobiology       Date:  2010-06-22       Impact factor: 3.144

3.  Rescue of autoimmune hepatitis by soluble MHC class II molecules in an altered concanavalin A-induced experimental model.

Authors:  Katerina Bakela; Maria Georgia Dimitraki; Evangelia Skoufa; Irene Athanassakis
Journal:  Animal Model Exp Med       Date:  2020-08-27

4.  Medullary thymic epithelial cell depletion leads to autoimmune hepatitis.

Authors:  Anthony J Bonito; Costica Aloman; M Isabel Fiel; Nichole M Danzl; Sungwon Cha; Erica G Weinstein; Seihwan Jeong; Yongwon Choi; Matthew C Walsh; Konstantina Alexandropoulos
Journal:  J Clin Invest       Date:  2013-07-15       Impact factor: 14.808

5.  Development of a spontaneous liver disease resembling autoimmune hepatitis in mice lacking tyro3, axl and mer receptor tyrosine kinases.

Authors:  Nan Qi; Peipei Liu; Yue Zhang; Hui Wu; Yongmei Chen; Daishu Han
Journal:  PLoS One       Date:  2013-06-17       Impact factor: 3.240

6.  Autoimmune hepatitis: a review of current diagnosis and treatment.

Authors:  Ashima Makol; Kymberly D Watt; Vaidehi R Chowdhary
Journal:  Hepat Res Treat       Date:  2011-05-15

7.  The CYP2D6 animal model: how to induce autoimmune hepatitis in mice.

Authors:  Edith Hintermann; Janine Ehser; Urs Christen
Journal:  J Vis Exp       Date:  2012-02-03       Impact factor: 1.355

Review 8.  Medullary thymic epithelial cells and central tolerance in autoimmune hepatitis development: novel perspective from a new mouse model.

Authors:  Konstantina Alexandropoulos; Anthony J Bonito; Erica G Weinstein; Olivier Herbin
Journal:  Int J Mol Sci       Date:  2015-01-16       Impact factor: 5.923

Review 9.  Asialoglycoprotein receptor (ASGPR): a peculiar target of liver-specific autoimmunity.

Authors:  Dirk Roggenbuck; Maria G Mytilinaiou; Sergey V Lapin; Dirk Reinhold; Karsten Conrad
Journal:  Auto Immun Highlights       Date:  2012-10-30

10.  Experimental liver fibrosis research: update on animal models, legal issues and translational aspects.

Authors:  Christian Liedtke; Tom Luedde; Tilman Sauerbruch; David Scholten; Konrad Streetz; Frank Tacke; René Tolba; Christian Trautwein; Jonel Trebicka; Ralf Weiskirchen
Journal:  Fibrogenesis Tissue Repair       Date:  2013-10-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.